Molecular Docking Approach of Bryophyllum Pinnatum Compounds as Atherosclerosis Therapy By Targeting Adenosine Monophosphate-Activated Protein Kinase and Inducible Nitric Oxide Synthase
Authors:
Open Access
- 1 January 2022
- journal article
- research article
- Published by ScopeMed in Acta Informatica Medica
- Vol. 30 (1) , 91-95
Abstract
Background: Bryophyllum pinnatum is a herbal medicine from Indonesia which has an anti-inflammatory effect. Adenosine monophosphate-activated protein kinase (AMPK) and inducible nitric oxide synthase (iNOS) play a function in thickening and inflammation in atherosclerosis disease. Objective: This research aims conducted to know the potential of Bryophyllum pinnatum as a therapy for atherosclerosis by targeting AMPK and iNOS. Methods: We employed a molecular docking technique to interact active compounds of Bryohyllum pinnatum with AMPK and iNOS, which were retrieved on the protein databank. Molecular docking analysis utilizing tools such as Pyrx 9.5, Pymol, and Discovery Studio, to support the interaction between the compound and protein. Molecular Dynamic (MD) simulation also performed using CABS-FLEX 2.0 server to know the stability interaction. Results: Bryophillin B was an active compound that possesses significant binding to AMPK and iNOS. It had same binding pocket as native ligand, and Bryophyllin B has a stronger interaction with AMPK. Based on the RMSF, the interaction biding complex Bryophyllin B with AMPK and iNOS were stable Conclusion: Bryophillin B was predicted to have potential therapy for atherosclerosis disease.Keywords
This publication has 16 references indexed in Scilit:
- Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic DiseaseCirculation Research, 2016
- Discovery of a Natural Product-Like iNOS Inhibitor by Molecular Docking with Potential Neuroprotective Effects In VivoPLOS ONE, 2014
- Pathophysiology of Atherosclerosis Plaque ProgressionHeart, Lung and Circulation, 2013
- Inflammation in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Measuring and comparing structural fluctuation patterns in large protein datasetsBioinformatics, 2012
- Endothelial nitric oxide synthase Glu298Asp (G894T) gene polymorphism in coronary artery disease patients with type 2 diabetes mellitusDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2012
- Structural basis for compound C inhibition of the human AMP-activated protein kinase α2 subunit kinase domainActa Crystallographica Section D Structural Biology, 2011
- Multi-Targeted Natural Products Evaluation Based on Biological Activity Prediction with PASSCurrent Pharmaceutical Design, 2010
- iNOS-mediated nitric oxide production and its regulationLife Sciences, 2004
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001